Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, happy Friday! Let’s get into the news.

Otsuka tops Vera Therapeutics in kidney disease study showdown

From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.

To read the rest of this story subscribe to STAT+. Subscribe Log In

See Full Page